1. HLA-E and NKG2A as a novel immune checkpoint axis to improve treatment for non-muscle invasive bladder cancer

2. Characterizing the influence of the HLA class I and KIR genotypes on the efficacy of anti-NKG2A immunotherapy

3. Genetic and Environmental Determinants of NK cell and T cell Functions in Kidney Transplantation

4. Characterizing the effects of HLA class I and KIR immunogenetics on ILC/NK cell development in human tonsils

5. Characterizing the effects of HLA class I and KIR immunogenetics on ILC/NK cell development in bone marrow failure and on hematopoiesis